These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 29117503)

  • 21. Solubility enhancement of BCS Class II drug by solid phospholipid dispersions: Spray drying versus freeze-drying.
    Fong SY; Ibisogly A; Bauer-Brandl A
    Int J Pharm; 2015 Dec; 496(2):382-91. PubMed ID: 26468038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expanding the Application and Formulation Space of Amorphous Solid Dispersions with KinetiSol®: a Review.
    Ellenberger DJ; Miller DA; Williams RO
    AAPS PharmSciTech; 2018 Jul; 19(5):1933-1956. PubMed ID: 29846889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amorphous Solid Dispersions: Utilization and Challenges in Drug Discovery and Development.
    He Y; Ho C
    J Pharm Sci; 2015 Oct; 104(10):3237-58. PubMed ID: 26175316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent studies on the processes and formulation impacts in the development of solid dispersions by hot-melt extrusion.
    Tran PHL; Lee BJ; Tran TTD
    Eur J Pharm Biopharm; 2021 Jul; 164():13-19. PubMed ID: 33887388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.
    Vo CL; Park C; Lee BJ
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):799-813. PubMed ID: 24056053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Overview on Recent Patents and Technologies on Solid Dispersion.
    Kaushik R; Budhwar V; Kaushik D
    Recent Pat Drug Deliv Formul; 2020; 14(1):63-74. PubMed ID: 31951172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening of drug-sericin solid dispersions for improved solubility and dissolution.
    Salunkhe NH; Jadhav NR; More HN; Jadhav AD
    Int J Biol Macromol; 2018 Feb; 107(Pt B):1683-1691. PubMed ID: 29030184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manufacturing strategies to develop amorphous solid dispersions: An overview.
    Mendonsa N; Almutairy B; Kallakunta VR; Sarabu S; Thipsay P; Bandari S; Repka MA
    J Drug Deliv Sci Technol; 2020 Feb; 55():. PubMed ID: 32863891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of polymer type on bioperformance and physical stability of hot melt extruded formulations of a poorly water soluble drug.
    Mitra A; Li L; Marsac P; Marks B; Liu Z; Brown C
    Int J Pharm; 2016 May; 505(1-2):107-14. PubMed ID: 27012984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nano Spray-Dried Drugs for Oral Administration: A Review.
    Öztürk AA; Arpagaus C
    Assay Drug Dev Technol; 2021 Oct; 19(7):412-441. PubMed ID: 34550790
    [No Abstract]   [Full Text] [Related]  

  • 31. Nano spray drying for encapsulation of pharmaceuticals.
    Arpagaus C; Collenberg A; Rütti D; Assadpour E; Jafari SM
    Int J Pharm; 2018 Jul; 546(1-2):194-214. PubMed ID: 29778825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.
    Vasconcelos T; Sarmento B; Costa P
    Drug Discov Today; 2007 Dec; 12(23-24):1068-75. PubMed ID: 18061887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using Acetone/Water Binary Solvent to Enhance the Stability and Bioavailability of Spray Dried Enzalutamide/HPMC-AS Solid Dispersions.
    Zhang X; Rao Q; Qiu Z; Lin Y; Zhang L; Hu Q; Chen T; Ma Z; Gao H; Luo D; Zhao J; Ouyang D; Zhang ZJ; Li Q
    J Pharm Sci; 2021 Mar; 110(3):1160-1171. PubMed ID: 33049259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current Trends in Self-Emulsifying Drug Delivery Systems (SEDDSs) to Enhance the Bioavailability of Poorly Water-Soluble Drugs.
    Karwal R; Garg T; Rath G; Markandeywar TS
    Crit Rev Ther Drug Carrier Syst; 2016; 33(1):1-39. PubMed ID: 27279337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Building a better particle: Leveraging physicochemical understanding of amorphous solid dispersions and a hierarchical particle approach for improved delivery at high drug loadings.
    Schenck L; Mann AKP; Liu Z; Milewski M; Zhang S; Ren J; Dewitt K; Hermans A; Cote A
    Int J Pharm; 2019 Mar; 559():147-155. PubMed ID: 30654058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hot melt extrusion versus spray drying: hot melt extrusion degrades albendazole.
    Hengsawas Surasarang S; Keen JM; Huang S; Zhang F; McGinity JW; Williams RO
    Drug Dev Ind Pharm; 2017 May; 43(5):797-811. PubMed ID: 27616147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of self-dispersible dry nanosuspension through wet milling and spray freeze-drying for poorly water-soluble drugs.
    Niwa T; Danjo K
    Eur J Pharm Sci; 2013 Nov; 50(3-4):272-81. PubMed ID: 23907001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of supercritical fluid technology for solid dispersion to enhance solubility and bioavailability of poorly water-soluble drugs.
    Tran P; Park JS
    Int J Pharm; 2021 Dec; 610():121247. PubMed ID: 34740762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solubilization of poorly water-soluble drugs using solid dispersions.
    Tran TT; Tran PH; Khanh TN; Van TV; Lee BJ
    Recent Pat Drug Deliv Formul; 2013 Aug; 7(2):122-33. PubMed ID: 23244679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
    Meng F; Gala U; Chauhan H
    Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.